Repligen Corp. (RGEN)

167.60 -2.01 (-1.19%) USD  |  NASDAQ  |  Sep 04, 16:00
167.57 -0.03 (-0.02%) Pre-Market: 20:00
More

Repligen Annual EPS GAAP Estimates

Annual EPS GAAP Estimates Chart

View Annual EPS GAAP Estimates for RGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual EPS GAAP Estimates Chart
Start Trial

Historical Annual EPS GAAP Estimates Data

View and export this data back to 2024. Start Trial.
Date Value
December 31, 2028 --
December 31, 2027 --
December 31, 2026 --
Date Value
December 31, 2025 --
December 31, 2024 --

Annual EPS GAAP Estimates Range, Past 5 Years

View Annual EPS GAAP Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual EPS GAAP Estimates Benchmarks

View Annual EPS GAAP Estimates Benchmarks
Start Trial
BioLife Solutions, Inc. Upgrade
Anika Therapeutics, Inc. Upgrade
Danaher Corp. Upgrade
Liquidia Corp. Upgrade
Harmony Biosciences Holdings, Inc. Upgrade